Bordet Scientific Publications

Bordet Scientific Publications

  • An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.

  • Auteurs Houda I, Bahce I, Dickhoff C, Kroese TE, Kroeze SGC, Mariolo AV, Tagliamento M, Moliner L, Brandão M, Pretzenbacher Y, Edwards J, Opitz I, Brunelli A, Guckenberger M, van Schil PE, Popat S, Blum T, Faivre-Finn C, de Ruysscher D, Remon J, Berghmans T, Dingemans AC, Besse B, Hendriks LEL
  • Auteurs (entité) BERGHMANS THIERRY
  • Revue Lung Cancer
  • Date de publication 2024-12
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.
  • Best practice guidelines for use of reference points in radiation oncology information systems to aggregate longitudinal dosimetric data.

  • Auteurs Witztum A, Jourani Y, Hirata EY, McNutt T, Purdie TG, Brock KK, Hong DS, Howard ME, Krauze AV, Balter PA, Stockham AL, Covington E, Xiao Y, Popple R, Mayo CS
  • Auteurs (entité) JOURANI Younes
  • Revue Pract Radiat Oncol
  • Date de publication 2024-11
Best practice guidelines for use of reference points in radiation oncology information systems to aggregate longitudinal dosimetric data.
  • EchiNam: multicenter retrospective study on the experience, challenges, and pitfalls in the diagnosis and treatment of alveolar echinococcosis in Belgium.

  • Auteurs Plum PE, Ausselet N, Kidd F, Noirhomme S, Garrino MG, Dili A, Hayette MP, Detry O, Leonard P, Motet C, Hites M, Bourgeois M, Montesinos I, Delaere B
  • Auteurs (entité) MOTET CHRISTIAN
  • Revue Eur J Clin Microbiol Infect Dis
  • Date de publication 2024-11
EchiNam: multicenter retrospective study on the experience, challenges, and pitfalls in the diagnosis and treatment of alveolar echinococcosis in Belgium.
  • Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.

  • Auteurs De Jaeghere EA, Tuyaerts S, Van Nufel AMT, Belmans A, Bogaerts K, Baiden-Amissah R, Lippens L, Vuylsteke P, Henry S, Trinh XB, van Dam PA, Aspeslagh S, De Caluwé A, Naert E, Lambrechts D, Hendrix A, De Wever O, Van de Vijver KK, Amant F, Vandecasteele K, Denys HG
  • Auteurs (entité) DE CALUWE ALEX
  • Revue Cancer Immunol Immunother
  • Date de publication 2024-12
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study.
Erasme hospital

Erasmus Hospital

View all of Erasmus's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications